Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Drug Screening Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Medical Devices & Consumables / Global Drug Screening Market

Global Drug Screening Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Medical Devices & Consumables Aug 2018 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Drug Screening Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

EXTENT RESEARCH published the latest report on global Drug Screening Market with the goal of offering the complete market statistics and analytics to the readers all under a single roof. This report covers in-depth knowledge regarding the qualitative and quantitative market study to help clients gain a better understanding of the future market position. Global Drug Screening market report primarily provides evidences which are responsible for the significant growth of the market. These evidences include market dynamics, consumer behavior, growth stimulators, geographical distribution, and competitive landscape. The geographical segment analysis sheds light on the regional & environmental impact on the market as well as the position of the market on both the regional and global platform in terms of finance and product popularity.

Data provided by Extent Research. Source: https://www.extentresearch.com/drug-screening-market

Segmentation of the Global Drug Screening Market:

By Type

  • Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents,

By Application

  • Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others,

Some of the regions exhibiting a distinct growth platform for the global Drug Screening market includes:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa

Most importantly, the report represents all the financial and market analytics to offer a better insight on the market status and profitable gains during the forecast period. Furthermore, the detailed study on the competitive landscape is a mirror view of the markets future expansions among the key market participants. The market research facts such as sales & marketing, distribution, new product launches, latest manufacturing trends, and financial gains are also well mentioned the Drug Screening market report. The key market players dominating the global Drug Screening market includes: Abbott, Express Diagnostics, Laboratory Corporation of America, MPD, Quest Diagnostics, Roche Diagnostics, Shimadzu, Siemens Healthcare, Thermo Fisher Scientific, .

In the conclusion, the global Drug Screening market report includes certain market facts such as opportunities & challenges, regional analysis, competitive landscape study, latest market trends, market size, share, revenue, market dynamics, and forecast details. At, Extent Research, we ensure that all the global Drug Screening market related details is provided to the readers for helping them reach their business growth targets through the smart thinking.

Report Scope and Market Segmentation

ATTRIBUTES Global Drug Screening Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Drug Screening Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Study Coverage 1.1 Drug Screening Product Introduction 1.2 Market by Type 1.2.1 Global Drug Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 Immunoassay Analyzers 1.2.3 Chromatography 1.2.4 Breath Analyzers 1.2.5 Rapid Testing Devices 1.2.6 Assay Kits and Reagents 1.3 Market by Application 1.3.1 Global Drug Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Hospitals 1.3.3 Research Institute 1.3.4 Biotechnology & Pharmaceutical Companies 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Drug Screening Sales Estimates and Forecasts 2017-2035 2.2 Global Drug Screening Revenue Estimates and Forecasts 2017-2035 2.3 Global Drug Screening Revenue by Region: 2017 VS 2021 VS 2035 2.4 Global Drug Screening Sales by Region 2.4.1 Global Drug Screening Sales by Region (2017-2022) 2.4.2 Global Sales Drug Screening by Region (2023-2035) 2.5 Global Drug Screening Revenue by Region 2.5.1 Global Drug Screening Revenue by Region (2017-2022) 2.5.2 Global Drug Screening Revenue by Region (2023-2035) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Drug Screening Sales by Manufacturers 3.1.1 Global Top Drug Screening Manufacturers by Sales (2017-2022) 3.1.2 Global Drug Screening Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Screening in 2021 3.2 Global Drug Screening Revenue by Manufacturers 3.2.1 Global Drug Screening Revenue by Manufacturers (2017-2022) 3.2.2 Global Drug Screening Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Drug Screening Revenue in 2021 3.3 Global Drug Screening Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Drug Screening Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Drug Screening Sales by Type 4.1.1 Global Drug Screening Historical Sales by Type (2017-2022) 4.1.2 Global Drug Screening Forecasted Sales by Type (2023-2035) 4.1.3 Global Drug Screening Sales Market Share by Type (2017-2035) 4.2 Global Drug Screening Revenue by Type 4.2.1 Global Drug Screening Historical Revenue by Type (2017-2022) 4.2.2 Global Drug Screening Forecasted Revenue by Type (2023-2035) 4.2.3 Global Drug Screening Revenue Market Share by Type (2017-2035) 4.3 Global Drug Screening Price by Type 4.3.1 Global Drug Screening Price by Type (2017-2022) 4.3.2 Global Drug Screening Price Forecast by Type (2023-2035) 5 Market Size by Application 5.1 Global Drug Screening Sales by Application 5.1.1 Global Drug Screening Historical Sales by Application (2017-2022) 5.1.2 Global Drug Screening Forecasted Sales by Application (2023-2035) 5.1.3 Global Drug Screening Sales Market Share by Application (2017-2035) 5.2 Global Drug Screening Revenue by Application 5.2.1 Global Drug Screening Historical Revenue by Application (2017-2022) 5.2.2 Global Drug Screening Forecasted Revenue by Application (2023-2035) 5.2.3 Global Drug Screening Revenue Market Share by Application (2017-2035) 5.3 Global Drug Screening Price by Application 5.3.1 Global Drug Screening Price by Application (2017-2022) 5.3.2 Global Drug Screening Price Forecast by Application (2023-2035) 6 North America 6.1 North America Drug Screening Market Size by Type 6.1.1 North America Drug Screening Sales by Type (2017-2035) 6.1.2 North America Drug Screening Revenue by Type (2017-2035) 6.2 North America Drug Screening Market Size by Application 6.2.1 North America Drug Screening Sales by Application (2017-2035) 6.2.2 North America Drug Screening Revenue by Application (2017-2035) 6.3 North America Drug Screening Market Size by Country 6.3.1 North America Drug Screening Sales by Country (2017-2035) 6.3.2 North America Drug Screening Revenue by Country (2017-2035) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Drug Screening Market Size by Type 7.1.1 Europe Drug Screening Sales by Type (2017-2035) 7.1.2 Europe Drug Screening Revenue by Type (2017-2035) 7.2 Europe Drug Screening Market Size by Application 7.2.1 Europe Drug Screening Sales by Application (2017-2035) 7.2.2 Europe Drug Screening Revenue by Application (2017-2035) 7.3 Europe Drug Screening Market Size by Country 7.3.1 Europe Drug Screening Sales by Country (2017-2035) 7.3.2 Europe Drug Screening Revenue by Country (2017-2035) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Drug Screening Market Size by Type 8.1.1 Asia Pacific Drug Screening Sales by Type (2017-2035) 8.1.2 Asia Pacific Drug Screening Revenue by Type (2017-2035) 8.2 Asia Pacific Drug Screening Market Size by Application 8.2.1 Asia Pacific Drug Screening Sales by Application (2017-2035) 8.2.2 Asia Pacific Drug Screening Revenue by Application (2017-2035) 8.3 Asia Pacific Drug Screening Market Size by Region 8.3.1 Asia Pacific Drug Screening Sales by Region (2017-2035) 8.3.2 Asia Pacific Drug Screening Revenue by Region (2017-2035) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Drug Screening Market Size by Type 9.1.1 Latin America Drug Screening Sales by Type (2017-2035) 9.1.2 Latin America Drug Screening Revenue by Type (2017-2035) 9.2 Latin America Drug Screening Market Size by Application 9.2.1 Latin America Drug Screening Sales by Application (2017-2035) 9.2.2 Latin America Drug Screening Revenue by Application (2017-2035) 9.3 Latin America Drug Screening Market Size by Country 9.3.1 Latin America Drug Screening Sales by Country (2017-2035) 9.3.2 Latin America Drug Screening Revenue by Country (2017-2035) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Drug Screening Market Size by Type 10.1.1 Middle East and Africa Drug Screening Sales by Type (2017-2035) 10.1.2 Middle East and Africa Drug Screening Revenue by Type (2017-2035) 10.2 Middle East and Africa Drug Screening Market Size by Application 10.2.1 Middle East and Africa Drug Screening Sales by Application (2017-2035) 10.2.2 Middle East and Africa Drug Screening Revenue by Application (2017-2035) 10.3 Middle East and Africa Drug Screening Market Size by Country 10.3.1 Middle East and Africa Drug Screening Sales by Country (2017-2035) 10.3.2 Middle East and Africa Drug Screening Revenue by Country (2017-2035) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Overview 11.1.3 Abbott Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Abbott Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Abbott Recent Developments 11.2 Express Diagnostics 11.2.1 Express Diagnostics Corporation Information 11.2.2 Express Diagnostics Overview 11.2.3 Express Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Express Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Express Diagnostics Recent Developments 11.3 Laboratory Corporation of America 11.3.1 Laboratory Corporation of America Corporation Information 11.3.2 Laboratory Corporation of America Overview 11.3.3 Laboratory Corporation of America Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Laboratory Corporation of America Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Laboratory Corporation of America Recent Developments 11.4 MPD 11.4.1 MPD Corporation Information 11.4.2 MPD Overview 11.4.3 MPD Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 MPD Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 MPD Recent Developments 11.5 Quest Diagnostics 11.5.1 Quest Diagnostics Corporation Information 11.5.2 Quest Diagnostics Overview 11.5.3 Quest Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Quest Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Quest Diagnostics Recent Developments 11.6 Roche Diagnostics 11.6.1 Roche Diagnostics Corporation Information 11.6.2 Roche Diagnostics Overview 11.6.3 Roche Diagnostics Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Roche Diagnostics Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Roche Diagnostics Recent Developments 11.7 Shimadzu 11.7.1 Shimadzu Corporation Information 11.7.2 Shimadzu Overview 11.7.3 Shimadzu Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Shimadzu Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Shimadzu Recent Developments 11.8 Siemens Healthcare 11.8.1 Siemens Healthcare Corporation Information 11.8.2 Siemens Healthcare Overview 11.8.3 Siemens Healthcare Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Siemens Healthcare Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Siemens Healthcare Recent Developments 11.9 Thermo Fisher Scientific 11.9.1 Thermo Fisher Scientific Corporation Information 11.9.2 Thermo Fisher Scientific Overview 11.9.3 Thermo Fisher Scientific Drug Screening Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Thermo Fisher Scientific Drug Screening Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Thermo Fisher Scientific Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Drug Screening Industry Chain Analysis 12.2 Drug Screening Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Drug Screening Production Mode & Process 12.4 Drug Screening Sales and Marketing 12.4.1 Drug Screening Sales Channels 12.4.2 Drug Screening Distributors 12.5 Drug Screening Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Drug Screening Industry Trends 13.2 Drug Screening Market Drivers 13.3 Drug Screening Market Challenges 13.4 Drug Screening Market Restraints 14 Key Findings in The Global Drug Screening Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/drug-screening-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/drug-screening-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors